CPT® Code 82775

1. Indications

The quantitative analysis of galactose-1-phosphate uridyl transferase (GALT) is indicated for the following conditions:

• Classic Type Galactosemia This test is performed to diagnose classic type galactosemia, a genetic disorder characterized by the inability to metabolize galactose due to GALT deficiency.
• Newborn Screening GALT testing is part of newborn screening panels to identify infants at risk for metabolic disorders, allowing for early diagnosis and management.

2. Procedure

The procedure for performing the quantitative analysis of GALT involves several key steps:

• Step 1: Patient Preparation Prior to the blood draw, the patient may be instructed to fast or follow specific dietary guidelines to ensure accurate test results, although specific fasting requirements are not universally mandated.
• Step 2: Venipuncture A qualified healthcare professional performs venipuncture to obtain a blood sample. This involves using a sterile needle to access a vein, typically in the arm, and collecting the blood into a designated collection tube.
• Step 3: Sample Handling The collected blood sample is then properly labeled and transported to the laboratory for analysis. It is essential to handle the sample according to laboratory protocols to maintain its integrity.
• Step 4: Enzymatic Testing In the laboratory, the blood sample undergoes enzymatic testing to quantitatively measure the levels of GALT. This methodology allows for precise determination of enzyme activity, which is critical for diagnosing galactosemia.
• Step 5: Result Interpretation Once the analysis is complete, the results are interpreted by a qualified healthcare professional. Elevated or absent levels of GALT in the blood indicate a potential diagnosis of galactosemia, prompting further clinical evaluation and management.

3. Post-Procedure

After the procedure, patients may experience minimal discomfort at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for this test, but patients should be advised to monitor the site for any unusual symptoms, such as excessive bleeding or signs of infection. The results of the GALT quantitative analysis will be communicated to the healthcare provider, who will discuss the findings and any necessary follow-up actions, including potential dietary modifications or further testing if galactosemia is suspected.